Skip to main content
SpringerLink
Log in

Gegenwärtiger Stand der Therapie des Ovarialkarzinoms

  • Conference paper
Ovarialtumoren

  • 31 Accesses

Zusammenfassung

Die Heilungsergebnisse beim Ovarialkarzinom sind nach wie vor schlecht, bedingt in erster Linie durch die hohe Zahl forgeschrittener, zur Behandlung kommender Karzinome und durch deren begrenzte therapeutische Beeinflußbarkeit (Abb. 1). Die Fünfjahresergebnisse für das Stadium III liegen auch in hochqualifizierten Zentren bei etwa 15%, die Zehnjahresergebnisse bei etwa 12% [15] (Abb. 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ausschuß Onkologie der Deutschen Gesellschaft Gynäkologie, Geburtshilfe (1981) Zur gegenwärtigen Situation der Diagnostik und Therapie des Ovarialcarcinoms. Mitt Dtsch Ges Gynaekol Geburtshilfe 5:III.

    Google Scholar 

  2. Bush RS, Dembo AJ (1980) Current status of treatment for patients with ovarian cancer. In: Newman CE, Ford CHJ, Jordan IA (eds) Ovarian Cancer. Pergamon, Oxford New York.

    Google Scholar 

  3. Editorial (1980) Management of advanced ovarian cancer. Lancet II: 1010.

    Google Scholar 

  4. Griffith CT, Parker LM, Fuller AF (1979) Role of cytoreductive surgical treatment in the management of advanced ovarian. Cancer Treat Rep 63:235.

    Google Scholar 

  5. Kaufmann M (1980) Clinical application of in vitro chemosensitivity testing. In: Newman CE, Ford CHJ, Jordan IA (eds) Ovarian Cancer. Pergamon, Oxford New York.

    Google Scholar 

  6. Kolstad P (1980) Prognostic indicators and staging. In: Newman CE, Ford CHJ, Jordan IA (eds) Ovarian Cancer. Pergamon, Oxford New York.

    Google Scholar 

  7. Kolstad P, Davy M, Hoeg K (1977) Individualized treatment of ovarian cancer. Am J Obstet Gynecol 128:617.

    PubMed  CAS  Google Scholar 

  8. Lewis GC, Blessing J (1977) Ovarian Cancer: use of multiple modality programs involving surgery, radiation therapy and chemotherapy. Cancer 40:588.

    Article  PubMed  Google Scholar 

  9. Lewis B, Young R (1980) Adjuvant and first line chemotherapy for ovarian cancer. In: Newman CE, Ford CHJ, Jordan IA (eds) Ovarian Cancer. Pergamon, Oxford New York.

    Google Scholar 

  10. Lewis B, Young R (1980) Ovarian Cancer — Future approuches to the development of treatment. In: Newman CE, Ford CHJ, Jordan IA (eds) Ovarian Cancer. Pergamon, Oxford New York.

    Google Scholar 

  11. Pezner RD, Stevens K, Tong D, Allen CV (1978) Limited epithelial carcinoma of the ovary treated with curative intent by the intraperitoneal instillation of radiocolloids. Cancer 42:2563.

    Article  PubMed  CAS  Google Scholar 

  12. Rutledge F (1980) Das Ovarialcarcinom. Referat, Fortbildungskurs der I. Frauenklinik der Universität München, 21./22. 3. 1980.

    Google Scholar 

  13. Schwartz PE, Smith JP (1980) Second look operations in ovarian cancer. Am J Obstet Gynecol 138:1124.

    PubMed  CAS  Google Scholar 

  14. Smith JP (1978) Treatment of ovarian cancer. Adv Chemother Japan Sci Soc Press, Tokyo/Univ. Park Press, Baltimore.

    Google Scholar 

  15. Smith JP (1978) Surgery for ovarian cancer. In: Newman CE, Ford CHJ, Jordan IA (eds) Ovarian Cancer. Pergamon, Oxford New York.

    Google Scholar 

  16. Schüren E von der, Bojärt W, Gonzalez D (1980) Role of radiotherapy in the treatment of ovarian cancer. In: Newman CE, Ford CHJ, Jordan JA (eds) Ovarian Cancer. Pergamon, Oxford New York.

    Google Scholar 

  17. Volm M, Wayss K, Kaufmann M, Mattern J (1979) Therapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer 15:983.

    Article  PubMed  CAS  Google Scholar 

  18. Welander C, Kjorstat E, Kolstad P (1978) Postoperative indication and chemotherapy in patients with advanced ovarian cancer. Acta Obstet Gynecol Scand 57:161.

    Article  PubMed  CAS  Google Scholar 

  19. Wiltshaw E (1980) Cis-platinum in adenocarcinom of the ovary: A critical review. In: Newman CE, Ford CHJ, Jordan JA (eds) Ovarian Cancer. Pergamon, Oxford New York.

    Google Scholar 

  20. Young RC, Chabner BA et al. (1978) Advanced ovarian adenocarcinoma: a prospective clinical trial of melphalan versus combination chemotherapy. N Engl J Med 299:1261.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Frauenklinik, Voßstraße 9, D-6900, Heidelberg, Germany

    F. Kubli

Authors
  1. F. Kubli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Leiterin der Abteilung für gynäkologische Morphologie und morphologische Forschung, Universitäts-Frauenklinik, 6800, Mannheim, Germany

    Gisela Dallenbach-Hellweg (Professor für allgemeine Pathologie und pathologische Anatomie) (Professor für allgemeine Pathologie und pathologische Anatomie)

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kubli, F. (1982). Gegenwärtiger Stand der Therapie des Ovarialkarzinoms. In: Dallenbach-Hellweg, G. (eds) Ovarialtumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68462-3_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68462-3_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-11327-0

  • Online ISBN: 978-3-642-68462-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation